Use and Eligibility for Glucose-Like Peptide-1 Receptor Agonist Treatment for Primary Prevention of Stroke. Wilson LM, Anderson TS. Neurology 2025;104:e213739.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wilson LM, Anderson TS. Use and Eligibility for Glucose-Like Peptide-1 Receptor Agonist Treatment for Primary Prevention of Stroke. Neurology 2025;104:e213739.
PMID: 40408626